Skip to main content

Research Repository

Advanced Search

All Outputs (2)

Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT (2018)
Journal Article
Howard, R., Cort, E., Bradley, R., Harper, E., Kelly, L., Bentham, P., …Gray, R. (2018). Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT. Health Technology Assessment, 22(67), 1-62. https://doi.org/10.3310/hta22670

© Queen's Printer and Controller of HMSO 2018. Background: Very late-onset (aged ≥60 years) schizophrenia-like psychosis (VLOSLP) occurs frequently but no placebo-controlled, randomised trials have assessed the efficacy or risks of antipsychotic trea... Read More about Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.

Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial (2018)
Journal Article
Howard, R., Cort, E., Bradley, R., Harper, E., Kelly, L., Bentham, P., …Gray, R. (2018). Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial. Lancet Psychiatry, 5(7), 553-563. https://doi.org/10.1016/S2215-0366%2818%2930141-X

Background Very late (aged ≥60 years) onset schizophrenia-like psychosis occurs frequently but no placebo-controlled, randomised trials have assessed the efficacy and risks of antipsychotic treatment. We investigated whether low-dose amisulpride (... Read More about Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.